Anneleen Mortier

Accelerated wound healing in mice by on-site production and delivery of CXCL12 by transformed lactic acid bacteria

Truncation of CXCL12 by CD26 reduces its CXC chemokine receptor 4- and atypical chemokine receptor 3-dependent activity on endothelial cells and lymphocytes

CXCL9-Derived Peptides Differentially Inhibit Neutrophil Migration In Vivo through Interference with Glycosaminoglycan Interactions

CD26/dipeptidylpeptidase IV—chemokine interactions: double-edged regulation of inflammation and tumor biology

Regulation of Chemokine Activity – A Focus on the Role of Dipeptidyl Peptidase IV/CD26

Tuning the Selectivity and Reactivity of Metal‐Substituted Polyoxometalates as Artificial Proteases by Varying the Nature of the Embedded Lewis Acid Metal Ion

The Positively Charged COOH-terminal Glycosaminoglycan-binding CXCL9(74–103) Peptide Inhibits CXCL8-induced Neutrophil Extravasation and Monosodium Urate Crystal-induced Gout in Mice

BAL neutrophilia in azithromycin-treated lung transplant recipients: Clinical significance

Differential Cytokine, Chemokine and Growth Factor Expression in Phenotypes of Chronic Lung Allograft Dysfunction

Azithromycin and the Treatment of Lymphocytic Airway Inflammation After Lung Transplantation

Regulation of TNF‐α with a focus on rheumatoid arthritis

<i>In vivo</i> regulation of chemokine activity by post‐translational modification

Overview of the mechanisms regulating chemokine activity and availability